Medical Device Network on MSN3d
Abbott eyes intravascular lithotripsy market with clinical trial approvalThe US Food and Drug Administration (FDA) has granted Abbott an investigational device exemption to evaluate the company’s ...
Zacks Investment Research on MSN3d
ABT Stock to Gain From FDA IDE Approval for Its Coronary IVL SystemAbbott ABT has received the FDA’s investigational device exemption (IDE) for its Coronary Intravascular Lithotripsy (“IVL”) system to evaluate the treatment of severe calcification in coronary ...
The company is first rolling out the use of the Volt system among European Union doctors who have already gained experience ...
MTF Biologics, a global nonprofit organization that saves and heals lives by advancing tissue and organ donation, ...
Johnson & Johnson and Boston Scientific have also recently made moves to sell their own coronary intravascular lithotripsy ...
United Health Products, Inc. (OTCPK: UEEC) today provided an update on the company's regulatory and capital markets activities. As previously disclosed, the FDA requested that certain additional ...
The Volt PFA system. [Image courtesy of Abbott] Abbott (NYSE: ABT) + announced it received CE mark approval in Europe for its ...
GlobalData on MSN15d
FDA approves early feasibility study of Valcare’s transcatheter deviceThe FDA has approved Valcare Medical’s IDE application, allowing it to begin an EFS of Amend Trans-Septal System.
Lungpacer Medical, a leading neurostimulation company committed to advancing therapies that assist patients in overcoming the negative effects of mechanical ventilation (MV), is excited to announce ...
The AeroNova System is a novel, minimally invasive medical device designed to deliver continuous diaphragm neurostimulation in tandem with mechanical ventilation. The investigational device aims ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback